HHS and FDA Praise DEA's Initiative to Regulate Hazardous Enhanced 7-OH Substances
-
By
-
Assistant Secretary for Public Affairs (ASPA)
-
July 1, 2026
By
Assistant Secretary for Public Affairs (ASPA)
July 1, 2026
by Assistant Secretary for Public Affairs (ASPA)
July 1, 2026
A systematic review and meta-analysis found small, consistent reductions in craving across substance use disorders, while evidence for withdrawal symptoms and substance dependence remained limited.
August 10, 2026